Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.03B
- P/E ratio
- —
- EPS
- —
- Volume
- 3,095,643
- 52-week high
- —
- 52-week low
- —
- Open
- $2.40
- Day high
- $2.42
- Day low
- $2.26
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $49.8M | -$50.34M | -$0.14 |
| 2024 | $6M | -$200.4M | -$0.63 |
| 2023 | $1.11M | -$177.12M | -$0.80 |
| 2022 | $0 | -$101.94M | -$0.62 |
| 2021 | $0 | -$87.76M | -$0.60 |
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the end-to-end process of identifying, advancing, and bringing to market novel therapeutic compounds. Its development pipeline includes orally administered small molecule drug candidates such as Sotagliflozin, which has successfully concluded Phase III clinical studies for treating both heart failure and type 1 diabetes, and LX9211, currently undergoing Phase II clinical development for neuropathic pain. The firm maintains important strategic collaborations and licensing arrangements with pharmaceutical industry leaders, including Bristol-Myers Squibb Company and Genentech, Inc. Established in 1995, Lexicon Pharmaceuticals, Inc. is based in The Woodlands, Texas.
- CEO
- Michael S. Exton
- Employees
- 81
- Country
- US
- IPO date
- Apr 7, 2000
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Lexicon Pharmaceuticals, Inc.'s stock price today?
- LXRX is trading at $2.33 as of Jul 20, 2026.
- What is Lexicon Pharmaceuticals, Inc.'s market cap?
- Lexicon Pharmaceuticals, Inc. (LXRX) has a market capitalization of $1.03B.
- Does Lexicon Pharmaceuticals, Inc. pay a dividend?
- Lexicon Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Lexicon Pharmaceuticals, Inc. in?
- Lexicon Pharmaceuticals, Inc. operates in the Healthcare sector.